| Filed On | Filing |
|---|---|
| 08 Oct 2026 | FORM 6-K |
| 08 Oct 2026 | 424B3 |
| 06 Oct 2026 | EFFECT |
| 06 Oct 2026 | 424B3 |
| 21 Sep 2026 | FORM 6-K |
| 09 Sep 2026 | F-1 |
| 04 Sep 2026 |
Form 4: Sorrells Christopher Dixon, Director
Received 6,818 shares as a grant or award · Granted 11,065 Stock Option (right to buy) |
| 04 Sep 2026 | 10-Q/A |
| 18 Aug 2026 | FORM 6-K |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 10 Aug 2026 | SCHEDULE 13G |
| 07 Aug 2026 | SCHEDULE 13G/A |
| 24 Jul 2026 | SCHEDULE 13G |
| 21 Jul 2026 | Form 3: Harrison Norman, Director |
| 21 Jul 2026 |
Form 3: Laberge Michel, Founder and CSO
Holds 126,978 shares of Common Shares |
| 21 Jul 2026 |
Form 3: Crystal Robert J., Senior VP, Finance
Holds 21,919 shares of Common Shares |
| 20 Jul 2026 |
Form 3: Wilson Megan R., Chief Strategy Officer
Holds 51,150 shares of Common Stock |
| 20 Jul 2026 |
Form 3: Donaldson Ross M., Senior VP, Technology Developm
Holds 791 shares of Common Shares |
| 20 Jul 2026 |
Form 3: Little Mark S., Director
Holds 334,442 shares of Common Shares |
| 20 Jul 2026 |
Form 3: Laishley Jan L., Chief Ppl and Culture Officer
Holds 16,075 shares of Common Shares |
Loading...